Safety and Efficacy of Riluzole in French Patients With Spinocerebellar Ataxia Type 2
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL): a multicentre, randomised, double-blind, placebo-controlled trial
Lancet Neurol 2022 Mar 01;21(3)225-233, G Coarelli, A Heinzmann, C Ewenczyk, C Fischer, M Chupin, ML Monin, H Hurmic, F Calvas, P Calvas, C Goizet, S Thobois, M Anheim, K Nguyen, D Devos, C Verny, VAG Ricigliano, JF Mangin, A Brice, S Tezenas du Montcel, A DurrFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.